- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01735136
Efficacy and Safety of InSan Bamboo Salt on Improvement of Helicobacter Pylori Infection
August 21, 2019 updated by: Soo-Wan Chae, Chonbuk National University Hospital
The investigators performed a 4-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of InSan Bamboo Salt on improvement of Helicobacter pylori infection.
The investigators measured improvement of Helicobacter pylori infection parameters , including 14C-UBT(Urea breath test), and subjects' symptoms, and monitored their blood pressure.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Jeollabuk-do
-
Jeonju, Jeollabuk-do, Korea, Republic of, 560-822
- Clinical Trial Center for Functional Foods; Chonbuk National University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Males and females 19-65 years old
- 14C-UBT test ≥ 100 cpm
- Endoscopy results showing gastritis
- Able to give informed consent
Exclusion Criteria:
- Diagnosed of gastrointestinal disease such as ulcer, cancer, more than 10 erosions
- Taken antibiotics and stomach medicines such as steroid, bismuth compound, H2-receptor antagonist and proton pump inhibitor within 2 weeks
- Allergic or hypersensitive to any of the ingredients in the test products
- History of reaction to any of the test products or of gastrointestinal diseases such as Crohn's disease or gastrointestinal surgery
- History of alcohol or substance abuse
- Participation in any other clinical trials within past 2 months
- Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
- Pregnant or lactating women etc.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo
|
Placebo (10g/day)
|
|
Experimental: InSan Bamboo Salt
|
InSan Bamboo Salt (10g/day)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in 14C-UBT(Urea breath test)
Time Frame: 4 weeks
|
14C-UBT(Urea breath test) was measured in study visit 1(0 week) and visit 3(4 week).
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in subjects' symptoms
Time Frame: 4 weeks
|
subjects' symptoms was measured in study visit 1(0 week) and visit 3(4 week).
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 21, 2012
Primary Completion (Actual)
July 25, 2013
Study Completion (Actual)
July 25, 2013
Study Registration Dates
First Submitted
November 23, 2012
First Submitted That Met QC Criteria
November 23, 2012
First Posted (Estimate)
November 28, 2012
Study Record Updates
Last Update Posted (Actual)
August 26, 2019
Last Update Submitted That Met QC Criteria
August 21, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- INSAN-HP-BS
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Helicobacter Pylori Infection
-
Second Affiliated Hospital, School of Medicine,...CompletedHelicobacter Pylori Infection | Helicobacter Pylori Eradication AntibioticChina
-
Tanta UniversityRecruitingHELICOBACTER PYLORI INFECTIONS | Helicobacter Infection | Helicobacter Pylori Gastrointestinal Tract Infection | Helicobacter Pylori Infected PatientsEgypt
-
Christopher C. Thompson, MD, MScErbe Elektromedizin GmbHRecruitingHelicobacter Pylori Infection | H. Pylori Infection | Helicobacter Pylori | Helicobacter Pylori Gastrointestinal Tract Infection | H. Pylori Gastrointestinal DiseaseUnited States
-
Daewoong Pharmaceutical Co. LTD.iNtherapeutics Co. LTDCompletedHelicobacter Pylori Infection | Helicobacter Pylori Infected Subjects | Helicobacter Pylori Infected PatientsSouth Korea
-
Shanghai Jiao Tong University School of MedicineRecruiting
-
Peking University First HospitalRecruitingHelicobacter Pylori InfectionChina
-
Shanghai Zhongshan HospitalNot yet recruiting
-
Kaohsiung Medical UniversityKaohsiung Veterans General Hospital.RecruitingHelicobacter Pylori InfectionTaiwan
-
Yueyue LiQilu Hospital of Shandong University; Shandong University of Traditional Chinese... and other collaboratorsRecruitingHelicobacter Pylori InfectionChina
-
Yueyue LiQilu Hospital of Shandong University; Shandong University of Traditional Chinese... and other collaboratorsCompletedHelicobacter Pylori InfectionChina
Clinical Trials on InSan Bamboo Salt
-
LG Household & Health Care Ltd.Seoul National UniversityCompleted
-
Heba HelalRecruiting
-
MorphoSys AGCompletedRheumatoid ArthritisBulgaria, Germany, Netherlands, Poland, Ukraine
-
Cairo UniversityNot yet recruitingEffectiveness of Charcoal-infused Versus Nylon Bristle Toothbrushes on Plaque Removal and Oral Bacterial Reduction in Children
-
NYU Langone HealthNot yet recruitingEnd Stage Kidney DiseaseUnited States
-
University of Southern DenmarkOdense University Hospital; Beckett Foundation; Danish Diabetes AcademyCompleted
-
National Taiwan University HospitalRecruiting
-
National Taiwan University HospitalRecruiting
-
Academia Sinica, TaiwanCompleted
-
University of DelawareCompletedCardiovascular Risk FactorUnited States